Log in to search using one of your social media accounts:

 

Electrochemotherapy in Breast Cancer - Discussion of the Method and Literature Review

Breast Care
Source: Breast Care - Category: Cancer & Oncology Source Type: research

Related Links:

Most women tend to overestimate their risk of breast cancer, according to research...Read more on AuntMinnie.comRelated Reading: At-risk women not receiving breast MRI scans Mammo recalls don't keep women from other tests Most women prefer annual breast cancer screening Women still value mammography's benefits over 'harms' Simple interventions reduce mammography recall rates
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Does aspirin or ibuprofen reduce risk of HER2+ breast cancer?Breast Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
ConclusionsAlthough total nonvertebral fracture risk was higher among AI users, differences in hip fractures were not significant in a large population-based cohort of older women.Implications for Cancer SurvivorsUse of aromatase inhibitors by older women is associated with high risk for nonvertebral fracture that is increased compared with use of tamoxifen. Fracture risk should be assessed among patients taking these medications.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research
Publication date: Available online 14 December 2017 Source:The Journal of Steroid Biochemistry and Molecular Biology Author(s): René Maltais, Alexandre Trottier, Jenny Roy, Diana Ayan, Nicolas Bertrand, Donald Poirier The development of a covalent inhibitor of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) is a promising approach for the treatment of hormone-dependent breast cancer and endometriosis. After reporting the steroid derivative PBRM as a first potent covalent inhibitor of 17β-HSD1 without estrogenic activity, we are now interested in studying its pharmaceutical behavior. The metabolism...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
AbstractThe identification of patients at risk for breast cancer by genetic testing has proven to reduce breast cancer mortality. In 2010, due to a lack of systematization in hereditary cancer assistance in our center, we implemented a multidisciplinary Heredofamilial Cancer Unit (HFCU). We analyze if the HFCU improved the rates of referrals and preventive management of breast cancer patients with genetic risk. We retrospectively compared family history records, referrals of high-risk patients to genetic counseling, and detection and management of patients with BRCA1/2 mutations in two cohorts of breast cancer patients dia...
Source: Journal of Genetic Counseling - Category: Genetics & Stem Cells Source Type: research
BOSTON (CBS) – More than 40% of women in the United States have dense breasts which can make it hard to find small cancers on a mammogram, but researchers are testing a new technology that could help. It is a 3-dimensional ultrasound called SoftVue. During the exam, the patient lies on her stomach, and her breast is placed into a warm water bath. In two to four minutes, the machine creates a 3D image using sound waves. SoftVue exam (WBZ-TV) There is no radiation and no compression of the breast. While SoftVue probably would not replace a woman’s annual mammogram, it might be used in conjunction with mammography...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Breast Cancer Health Local News Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Source Type: news
Smith &Nephew has begun selling a handheld imaging device that can detect bacteria in hard-to-heal wounds and instantly measure wound surface area. MolecuLight i:X is already available in Canada, where its inventor stumbled across the idea for the device. Ralph DaCosta, MD, now a principal investigator at Princess Margaret Cancer Center in Toronto, was a PhD student researching fluorescent imaging of gastrointestinal cancer in 2007. The big, expensive device he was using didn’t produce any green images, which would have indicated cancer, but a red image that he couldn’t identify. DaCosta took a photo of th...
Source: MDDI - Category: Medical Devices Authors: Tags: Imaging Source Type: news
This article is protected by copyright. All rights reserved
Source: Journal of Cellular Physiology - Category: Cytology Authors: Tags: REVIEW ARTICLE Source Type: research
Conditions:   Breast Cancer;   Chemotherapy;   Endocrine Breast Diseases Interventions:   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Goserelin acetate;   Drug: Tamoxifen;   Drug: Letrozole Sponsor:   Zhiyong Yu Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Lymphedema Interventions:   Other: local distribution points association;   Other: local-distal points association;   Other: exercise with compression sleeve Sponsors:   Tianjin University of Traditional Chinese Medicine;   National Basic Research Program, China;   Tianjin Medical University Cancer Institute and Hospital;   The Second Affiliated Hospital of Baotou Medical College;   Henan Provincial Cancer Hospital;   Qilu Hospital of ...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology